Search
Matinas BioPharma Holdings Inc
MTNBAdd to Watchlist
0.290USD
-0.027-8.57%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.71MMarket Cap
LossP/E TTM
Matinas BioPharma Holdings Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Matinas BioPharma Holdings Inc is 8.70, ranking 66 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.15, which is -100.00% below the recent high of 0.00 and -4985.13% above the recent low of -7.56.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.